Galecto, Inc. (GLTO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
GLTO currently has 61.6M outstanding shares. with significant dilution risk as 61.4M authorized shares could dilute existing holders by 99.7%. The company has significantly diluted shareholders by 4452.56% over the past 2 years, indicating aggressive capital raising. Recent corporate actions include 1 stock split (positive for accessibility) and 1 reverse split (concerning signal).
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 61.6M shares outstanding |
62M | 61M |
| Mar 19, 2026 |
10-K filing | 60.3M shares outstanding |
60M | 61M |
| Jan 06, 2026 |
8-K filing: Galecto, Inc. issued a warrant to Paramora Holding LLC to purchase up to 628,302 shares of common stock at an exercise price of $23.01 per share on December 31, 2025. |
1.3M | 61M |
| Dec 16, 2025 |
S-3 filing: This prospectus relates to the proposed resale or other disposition by the selling stockholders of 60,513,309 shares of common stock. |
1.3M | 61M |
| Nov 06, 2025 |
10-Q filing | 1.3M shares outstanding |
1.3M | 850K |
| Aug 05, 2025 |
10-Q filing | 1.3M shares outstanding |
1.3M | 850K |
| May 08, 2025 |
10-Q filing | 1.3M shares outstanding |
1.3M | 850K |
| Mar 19, 2025 |
10-K filing | 1.3M shares outstanding |
1.3M | 850K |
| Nov 01, 2024 |
10-Q filing | 1.3M shares outstanding |
1.3M | 850K |
| Aug 29, 2024 |
Stock Split
8-K filing: Stock split 1-for-25 | Outstanding: 27,115,536 → 1,248,266 |
1.2M | 34K |
| Aug 12, 2024 |
10-Q filing | 27.1M shares outstanding |
27M | 21M |
| Apr 29, 2024 |
10-Q filing | 27.1M shares outstanding |
27M | 21M |
| Mar 08, 2024 |
10-K filing | 26.6M shares outstanding |
27M | 21M |
| Nov 06, 2023 |
10-Q filing | 27.1M shares outstanding |
27M | 21M |
| Jul 31, 2023 |
10-Q filing | 26.4M shares outstanding |
26M | 21M |
| Apr 28, 2023 |
10-Q filing | 25.7M shares outstanding |
26M | 21M |
| Mar 09, 2023 |
10-K filing | 25.4M shares outstanding |
25M | 21M |
| Nov 08, 2022 |
10-Q filing | 25.5M shares outstanding |
25M | 21M |
| Jul 29, 2022 |
10-Q filing | 25.4M shares outstanding |
25M | 21M |
| Apr 29, 2022 |
10-Q filing | 25.3M shares outstanding |
25M | 21M |
| Feb 17, 2022 |
10-K filing | 25.3M shares outstanding |
25M | 21M |
| Nov 04, 2021 |
S-3 filing: Galecto, Inc. files an S-3 to offer up to $200,000,000 of shares of its common stock, preferred stock, debt securities, warrants to purchase our common stock, preferred stock or debt securities, subscription rights to purchase our common stock, preferred stock or debt securities and/or units consisting of some or all of these securities. |
25M | 21M |
| Nov 04, 2021 |
10-Q filing | 25.3M shares outstanding |
25M | 21M |
| Aug 05, 2021 |
10-Q filing | 25.3M shares outstanding |
25M | 6.5M |
| May 04, 2021 |
10-Q filing | 25.3M shares outstanding |
25M | 6.5M |
| Mar 29, 2021 |
10-K filing | 25.3M shares outstanding |
25M | 6.5M |
| Dec 11, 2020 |
10-Q filing | 25.3M shares outstanding |
25M | 6.5M |
| Oct 22, 2020 |
S-1/A filing: This S-1/A filing outlines an offering of 5,666,667 shares of common stock at an initial public offering price of $15.00 per share, with an option for underwriters to purchase up to 850,000 additional shares. The company intends to use the net proceeds from this offering to fund the clinical development. |
25M | 6.5M |
| Oct 07, 2020 |
S-1 filing: This S-1 filing outlines the proposed offering of common stock and preferred stock, detailing the intended use of proceeds, risk factors, and financial data. |
N/A | 0 |